Shopping Cart 0
Cart Subtotal
AED 0

Global Neurodegenerative Diseases Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 12478

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 22754

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 22754

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 22754

Details

The Neurodegenerative Diseases market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Neurodegenerative Diseases market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Neurodegenerative Diseases market. The report focuses on well-known providers in the global Neurodegenerative Diseases industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Neurodegenerative Diseases Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Neurodegenerative Diseases market covered in Chapter 4:

H.Lundbeck A/S

Merck

Addex Pharmaceutical

Biogen Idec

Teva

Boehringer Ingelheim

Yumanity Therapeutics

UCB

Alector

Eisai

Asubio Pharmaceutical

Bial

AstraZeneca

Pfizer

Amarin

Bayer

Novartis

In Chapter 11 and 13.3, on the basis of types, the Neurodegenerative Diseases market from 2015 to 2026 is primarily split into:

NMDA

SSRIs

Dopamine Inhibitors

In Chapter 12 and 13.4, on the basis of applications, the Neurodegenerative Diseases market from 2015 to 2026 covers:

ParkinsonaEUR s Disease

Huntington Disease

Amyotrophic Lateral Sclerosis

AlzheimeraEUR s Disease

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Table Of Content

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Neurodegenerative Diseases Market Share by Type (2020-2026)

1.5.2 NMDA

1.5.3 SSRIs

1.5.4 Dopamine Inhibitors

1.6 Market by Application

1.6.1 Global Neurodegenerative Diseases Market Share by Application (2020-2026)

1.6.2 ParkinsonaEUR s Disease

1.6.3 Huntington Disease

1.6.4 Amyotrophic Lateral Sclerosis

1.6.5 AlzheimeraEUR s Disease

1.7 Neurodegenerative Diseases Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Neurodegenerative Diseases Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEUR s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Neurodegenerative Diseases Market

3.1 Value Chain Status

3.2 Neurodegenerative Diseases Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Neurodegenerative Diseases

3.2.3 Labor Cost of Neurodegenerative Diseases

3.2.3.1 Labor Cost of Neurodegenerative Diseases Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 H.Lundbeck A/S

4.1.1 H.Lundbeck A/S Basic Information

4.1.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.1.3 H.Lundbeck A/S Neurodegenerative Diseases Market Performance (2015-2020)

4.1.4 H.Lundbeck A/S Business Overview

4.2 Merck

4.2.1 Merck Basic Information

4.2.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.2.3 Merck Neurodegenerative Diseases Market Performance (2015-2020)

4.2.4 Merck Business Overview

4.3 Addex Pharmaceutical

4.3.1 Addex Pharmaceutical Basic Information

4.3.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.3.3 Addex Pharmaceutical Neurodegenerative Diseases Market Performance (2015-2020)

4.3.4 Addex Pharmaceutical Business Overview

4.4 Biogen Idec

4.4.1 Biogen Idec Basic Information

4.4.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.4.3 Biogen Idec Neurodegenerative Diseases Market Performance (2015-2020)

4.4.4 Biogen Idec Business Overview

4.5 Teva

4.5.1 Teva Basic Information

4.5.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.5.3 Teva Neurodegenerative Diseases Market Performance (2015-2020)

4.5.4 Teva Business Overview

4.6 Boehringer Ingelheim

4.6.1 Boehringer Ingelheim Basic Information

4.6.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.6.3 Boehringer Ingelheim Neurodegenerative Diseases Market Performance (2015-2020)

4.6.4 Boehringer Ingelheim Business Overview

4.7 Yumanity Therapeutics

4.7.1 Yumanity Therapeutics Basic Information

4.7.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.7.3 Yumanity Therapeutics Neurodegenerative Diseases Market Performance (2015-2020)

4.7.4 Yumanity Therapeutics Business Overview

4.8 UCB

4.8.1 UCB Basic Information

4.8.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.8.3 UCB Neurodegenerative Diseases Market Performance (2015-2020)

4.8.4 UCB Business Overview

4.9 Alector

4.9.1 Alector Basic Information

4.9.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.9.3 Alector Neurodegenerative Diseases Market Performance (2015-2020)

4.9.4 Alector Business Overview

4.10 Eisai

4.10.1 Eisai Basic Information

4.10.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.10.3 Eisai Neurodegenerative Diseases Market Performance (2015-2020)

4.10.4 Eisai Business Overview

4.11 Asubio Pharmaceutical

4.11.1 Asubio Pharmaceutical Basic Information

4.11.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.11.3 Asubio Pharmaceutical Neurodegenerative Diseases Market Performance (2015-2020)

4.11.4 Asubio Pharmaceutical Business Overview

4.12 Bial

4.12.1 Bial Basic Information

4.12.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.12.3 Bial Neurodegenerative Diseases Market Performance (2015-2020)

4.12.4 Bial Business Overview

4.13 AstraZeneca

4.13.1 AstraZeneca Basic Information

4.13.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.13.3 AstraZeneca Neurodegenerative Diseases Market Performance (2015-2020)

4.13.4 AstraZeneca Business Overview

4.14 Pfizer

4.14.1 Pfizer Basic Information

4.14.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.14.3 Pfizer Neurodegenerative Diseases Market Performance (2015-2020)

4.14.4 Pfizer Business Overview

4.15 Amarin

4.15.1 Amarin Basic Information

4.15.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.15.3 Amarin Neurodegenerative Diseases Market Performance (2015-2020)

4.15.4 Amarin Business Overview

4.16 Bayer

4.16.1 Bayer Basic Information

4.16.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.16.3 Bayer Neurodegenerative Diseases Market Performance (2015-2020)

4.16.4 Bayer Business Overview

4.17 Novartis

4.17.1 Novartis Basic Information

4.17.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.17.3 Novartis Neurodegenerative Diseases Market Performance (2015-2020)

4.17.4 Novartis Business Overview

5 Global Neurodegenerative Diseases Market Analysis by Regions

5.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Regions

5.1.1 Global Neurodegenerative Diseases Sales by Regions (2015-2020)

5.1.2 Global Neurodegenerative Diseases Revenue by Regions (2015-2020)

5.2 North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.3 Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.6 South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

6 North America Neurodegenerative Diseases Market Analysis by Countries

6.1 North America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

6.1.1 North America Neurodegenerative Diseases Sales by Countries (2015-2020)

6.1.2 North America Neurodegenerative Diseases Revenue by Countries (2015-2020)

6.1.3 North America Neurodegenerative Diseases Market Under COVID-19

6.2 United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

6.2.1 United States Neurodegenerative Diseases Market Under COVID-19

6.3 Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

6.4 Mexico Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7 Europe Neurodegenerative Diseases Market Analysis by Countries

7.1 Europe Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

7.1.1 Europe Neurodegenerative Diseases Sales by Countries (2015-2020)

7.1.2 Europe Neurodegenerative Diseases Revenue by Countries (2015-2020)

7.1.3 Europe Neurodegenerative Diseases Market Under COVID-19

7.2 Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.2.1 Germany Neurodegenerative Diseases Market Under COVID-19

7.3 UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.3.1 UK Neurodegenerative Diseases Market Under COVID-19

7.4 France Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.4.1 France Neurodegenerative Diseases Market Under COVID-19

7.5 Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.5.1 Italy Neurodegenerative Diseases Market Under COVID-19

7.6 Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.6.1 Spain Neurodegenerative Diseases Market Under COVID-19

7.7 Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.7.1 Russia Neurodegenerative Diseases Market Under COVID-19

8 Asia-Pacific Neurodegenerative Diseases Market Analysis by Countries

8.1 Asia-Pacific Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Neurodegenerative Diseases Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Neurodegenerative Diseases Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Neurodegenerative Diseases Market Under COVID-19

8.2 China Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.2.1 China Neurodegenerative Diseases Market Under COVID-19

8.3 Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.3.1 Japan Neurodegenerative Diseases Market Under COVID-19

8.4 South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.4.1 South Korea Neurodegenerative Diseases Market Under COVID-19

8.5 Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.6 India Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.6.1 India Neurodegenerative Diseases Market Under COVID-19

8.7 Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Neurodegenerative Diseases Market Under COVID-19

9 Middle East and Africa Neurodegenerative Diseases Market Analysis by Countries

9.1 Middle East and Africa Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Neurodegenerative Diseases Market Under COVID-19

9.2 Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.3 UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.4 Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.5 Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.6 South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10 South America Neurodegenerative Diseases Market Analysis by Countries

10.1 South America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

10.1.1 South America Neurodegenerative Diseases Sales by Countries (2015-2020)

10.1.2 South America Neurodegenerative Diseases Revenue by Countries (2015-2020)

10.1.3 South America Neurodegenerative Diseases Market Under COVID-19

10.2 Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10.2.1 Brazil Neurodegenerative Diseases Market Under COVID-19

10.3 Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10.4 Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10.5 Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

11 Global Neurodegenerative Diseases Market Segment by Types

11.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Neurodegenerative Diseases Sales and Market Share by Types (2015-2020)

11.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Types (2015-2020)

11.2 NMDA Sales and Price (2015-2020)

11.3 SSRIs Sales and Price (2015-2020)

11.4 Dopamine Inhibitors Sales and Price (2015-2020)

12 Global Neurodegenerative Diseases Market Segment by Applications

12.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Neurodegenerative Diseases Sales and Market Share by Applications (2015-2020)

12.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Applications (2015-2020)

12.2 ParkinsonaEUR s Disease Sales, Revenue and Growth Rate (2015-2020)

12.3 Huntington Disease Sales, Revenue and Growth Rate (2015-2020)

12.4 Amyotrophic Lateral Sclerosis Sales, Revenue and Growth Rate (2015-2020)

12.5 AlzheimeraEUR s Disease Sales, Revenue and Growth Rate (2015-2020)

13 Neurodegenerative Diseases Market Forecast by Regions (2020-2026)

13.1 Global Neurodegenerative Diseases Sales, Revenue and Growth Rate (2020-2026)

13.2 Neurodegenerative Diseases Market Forecast by Regions (2020-2026)

13.2.1 North America Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.2 Europe Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.3 Asia-Pacific Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.4 Middle East and Africa Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.5 South America Neurodegenerative Diseases Market Forecast (2020-2026)

13.3 Neurodegenerative Diseases Market Forecast by Types (2020-2026)

13.4 Neurodegenerative Diseases Market Forecast by Applications (2020-2026)

13.5 Neurodegenerative Diseases Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Neurodegenerative Diseases Market Size Growth Rate by Type (2020-2026)

Figure Global Neurodegenerative Diseases Market Share by Type in 2019 & 2026

Figure NMDA Features

Figure SSRIs Features

Figure Dopamine Inhibitors Features

Table Global Neurodegenerative Diseases Market Size Growth by Application (2020-2026)

Figure Global Neurodegenerative Diseases Market Share by Application in 2019 & 2026

Figure ParkinsonaEUR s Disease Description

Figure Huntington Disease Description

Figure Amyotrophic Lateral Sclerosis Description

Figure AlzheimeraEUR s Disease Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Neurodegenerative Diseases Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Neurodegenerative Diseases Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Neurodegenerative Diseases

Figure Production Process of Neurodegenerative Diseases

Figure Manufacturing Cost Structure of Neurodegenerative Diseases

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table H.Lundbeck A/S Profile

Table H.Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020

Table Merck Profile

Table Merck Production, Value, Price, Gross Margin 2015-2020

Table Addex Pharmaceutical Profile

Table Addex Pharmaceutical Production, Value, Price, Gross Margin 2015-2020

Table Biogen Idec Profile

Table Biogen Idec Production, Value, Price, Gross Margin 2015-2020

Table Teva Profile

Table Teva Production, Value, Price, Gross Margin 2015-2020

Table Boehringer Ingelheim Profile

Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020

Table Yumanity Therapeutics Profile

Table Yumanity Therapeutics Production, Value, Price, Gross Margin 2015-2020

Table UCB Profile

Table UCB Production, Value, Price, Gross Margin 2015-2020

Table Alector Profile

Table Alector Production, Value, Price, Gross Margin 2015-2020

Table Eisai Profile

Table Eisai Production, Value, Price, Gross Margin 2015-2020

Table Asubio Pharmaceutical Profile

Table Asubio Pharmaceutical Production, Value, Price, Gross Margin 2015-2020

Table Bial Profile

Table Bial Production, Value, Price, Gross Margin 2015-2020

Table AstraZeneca Profile

Table AstraZeneca Production, Value, Price, Gross Margin 2015-2020

Table Pfizer Profile

Table Pfizer Production, Value, Price, Gross Margin 2015-2020

Table Amarin Profile

Table Amarin Production, Value, Price, Gross Margin 2015-2020

Table Bayer Profile

Table Bayer Production, Value, Price, Gross Margin 2015-2020

Table Novartis Profile

Table Novartis Production, Value, Price, Gross Margin 2015-2020

Figure Global Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Global Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table Global Neurodegenerative Diseases Sales by Regions (2015-2020)

Table Global Neurodegenerative Diseases Sales Market Share by Regions (2015-2020)

Table Global Neurodegenerative Diseases Revenue (USD ) by Regions (2015-2020)

Table Global Neurodegenerative Diseases Revenue Market Share by Regions (2015-2020)

Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2015

Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2019

Figure North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure North America Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table North America Neurodegenerative Diseases Sales by Countries (2015-2020)

Table North America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2015

Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2019

Table North America Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Mexico Neurodegenerative Diseases Sales and Growth (2015-2020)

Figure Europe Neurodegenerative Diseases Revenue (USD ) Growth (2015-2020)

Table Europe Neurodegenerative Diseases Sales by Countries (2015-2020)

Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Figure Europe Neurodegenerative Diseases Sales Market Share by Countries in 2015

Figure Europe Neurodegenerative Diseases Sales Market Share by Countries in 2019

Table Europe Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure France Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Neurodegenerative Diseases Sales by Countries (2015-2020)

Table Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries in 2015

Figure Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries in 2019

Table Asia-Pacific Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure China Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure India Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South America Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table South America Neurodegenerative Diseases Sales by Countries (2015-2020)

Table South America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Table South America Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table South America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure South America Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure South America Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Table Global Neurodegenerative Diseases Sales by Types (2015-2020)

Table Global Neurodegenerative Diseases Sales Share by Types (2015-2020)

Table Global Neurodegenerative Diseases Revenue (USD ) by Types (2015-2020)

Table Global Neurodegenerative Diseases Revenue Share by Types (2015-2020)

Figure Global NMDA Sales and Growth Rate (2015-2020)

Figure Global NMDA Price (2015-2020)

Figure Global SSRIs Sales and Growth Rate (2015-2020)

Figure Global SSRIs Price (2015-2020)

Figure Global Dopamine Inhibitors Sales and Growth Rate (2015-2020)

Figure Global Dopamine Inhibitors Price (2015-2020)

Table Global Neurodegenerative Diseases Sales by Applications (2015-2020)

Table Global Neurodegenerative Diseases Sales Share by Applications (2015-2020)

Figure Global ParkinsonaEUR s Disease Sales and Growth Rate (2015-2020)

Figure Global ParkinsonaEUR s Disease Revenue and Growth Rate (2015-2020)

Figure Global Huntington Disease Sales and Growth Rate (2015-2020)

Figure Global Huntington Disease Revenue and Growth Rate (2015-2020)

Figure Global Amyotrophic Lateral Sclerosis Sales and Growth Rate (2015-2020)

Figure Global Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)

Figure Global AlzheimeraEUR s Disease Sales and Growth Rate (2015-2020)

Figure Global AlzheimeraEUR s Disease Revenue and Growth Rate (2015-2020)

Figure Global Neurodegenerative Diseases Sales and Growth Rate (2020-2026)

Figure Global Neurodegenerative Diseases Revenue (USD ) and Growth Rate (2020-2026)

Table Global Neurodegenerative Diseases Sales Forecast by Regions (2020-2026)

Table Global Neurodegenerative Diseases Revenue Forecast by Regions (2020-2026)

Figure North America Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure North America Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure Europe Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure Europe Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure Asia-Pacific Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure Asia-Pacific Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure Middle East and Africa Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure Middle East and Africa Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure South America Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure South America Neurodegenerative Diseases Revenue Forecast (2020-2026)

Table Global Neurodegenerative Diseases Sales Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Sales Market Share Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Revenue Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Sales Forecast by Applications (2020-2026)

Table Global Neurodegenerative Diseases Sales Market Share Forecast by Applications (2020-2026)

Table Global Neurodegenerative Diseases Revenue Forecast by Applications (2020-2026)

Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Applications (2020-2026)

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The Neurodegenerative Diseases market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Neurodegenerative Diseases market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Neurodegenerative Diseases market. The report focuses on well-known providers in the global Neurodegenerative Diseases industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Neurodegenerative Diseases Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Neurodegenerative Diseases market covered in Chapter 4:

H.Lundbeck A/S

Merck

Addex Pharmaceutical

Biogen Idec

Teva

Boehringer Ingelheim

Yumanity Therapeutics

UCB

Alector

Eisai

Asubio Pharmaceutical

Bial

AstraZeneca

Pfizer

Amarin

Bayer

Novartis

In Chapter 11 and 13.3, on the basis of types, the Neurodegenerative Diseases market from 2015 to 2026 is primarily split into:

NMDA

SSRIs

Dopamine Inhibitors

In Chapter 12 and 13.4, on the basis of applications, the Neurodegenerative Diseases market from 2015 to 2026 covers:

ParkinsonaEUR s Disease

Huntington Disease

Amyotrophic Lateral Sclerosis

AlzheimeraEUR s Disease

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

READ MORE

Scope

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Neurodegenerative Diseases Market Share by Type (2020-2026)

1.5.2 NMDA

1.5.3 SSRIs

1.5.4 Dopamine Inhibitors

1.6 Market by Application

1.6.1 Global Neurodegenerative Diseases Market Share by Application (2020-2026)

1.6.2 ParkinsonaEUR s Disease

1.6.3 Huntington Disease

1.6.4 Amyotrophic Lateral Sclerosis

1.6.5 AlzheimeraEUR s Disease

1.7 Neurodegenerative Diseases Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Neurodegenerative Diseases Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 PorteraEUR s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Neurodegenerative Diseases Market

3.1 Value Chain Status

3.2 Neurodegenerative Diseases Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Neurodegenerative Diseases

3.2.3 Labor Cost of Neurodegenerative Diseases

3.2.3.1 Labor Cost of Neurodegenerative Diseases Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 H.Lundbeck A/S

4.1.1 H.Lundbeck A/S Basic Information

4.1.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.1.3 H.Lundbeck A/S Neurodegenerative Diseases Market Performance (2015-2020)

4.1.4 H.Lundbeck A/S Business Overview

4.2 Merck

4.2.1 Merck Basic Information

4.2.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.2.3 Merck Neurodegenerative Diseases Market Performance (2015-2020)

4.2.4 Merck Business Overview

4.3 Addex Pharmaceutical

4.3.1 Addex Pharmaceutical Basic Information

4.3.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.3.3 Addex Pharmaceutical Neurodegenerative Diseases Market Performance (2015-2020)

4.3.4 Addex Pharmaceutical Business Overview

4.4 Biogen Idec

4.4.1 Biogen Idec Basic Information

4.4.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.4.3 Biogen Idec Neurodegenerative Diseases Market Performance (2015-2020)

4.4.4 Biogen Idec Business Overview

4.5 Teva

4.5.1 Teva Basic Information

4.5.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.5.3 Teva Neurodegenerative Diseases Market Performance (2015-2020)

4.5.4 Teva Business Overview

4.6 Boehringer Ingelheim

4.6.1 Boehringer Ingelheim Basic Information

4.6.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.6.3 Boehringer Ingelheim Neurodegenerative Diseases Market Performance (2015-2020)

4.6.4 Boehringer Ingelheim Business Overview

4.7 Yumanity Therapeutics

4.7.1 Yumanity Therapeutics Basic Information

4.7.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.7.3 Yumanity Therapeutics Neurodegenerative Diseases Market Performance (2015-2020)

4.7.4 Yumanity Therapeutics Business Overview

4.8 UCB

4.8.1 UCB Basic Information

4.8.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.8.3 UCB Neurodegenerative Diseases Market Performance (2015-2020)

4.8.4 UCB Business Overview

4.9 Alector

4.9.1 Alector Basic Information

4.9.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.9.3 Alector Neurodegenerative Diseases Market Performance (2015-2020)

4.9.4 Alector Business Overview

4.10 Eisai

4.10.1 Eisai Basic Information

4.10.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.10.3 Eisai Neurodegenerative Diseases Market Performance (2015-2020)

4.10.4 Eisai Business Overview

4.11 Asubio Pharmaceutical

4.11.1 Asubio Pharmaceutical Basic Information

4.11.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.11.3 Asubio Pharmaceutical Neurodegenerative Diseases Market Performance (2015-2020)

4.11.4 Asubio Pharmaceutical Business Overview

4.12 Bial

4.12.1 Bial Basic Information

4.12.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.12.3 Bial Neurodegenerative Diseases Market Performance (2015-2020)

4.12.4 Bial Business Overview

4.13 AstraZeneca

4.13.1 AstraZeneca Basic Information

4.13.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.13.3 AstraZeneca Neurodegenerative Diseases Market Performance (2015-2020)

4.13.4 AstraZeneca Business Overview

4.14 Pfizer

4.14.1 Pfizer Basic Information

4.14.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.14.3 Pfizer Neurodegenerative Diseases Market Performance (2015-2020)

4.14.4 Pfizer Business Overview

4.15 Amarin

4.15.1 Amarin Basic Information

4.15.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.15.3 Amarin Neurodegenerative Diseases Market Performance (2015-2020)

4.15.4 Amarin Business Overview

4.16 Bayer

4.16.1 Bayer Basic Information

4.16.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.16.3 Bayer Neurodegenerative Diseases Market Performance (2015-2020)

4.16.4 Bayer Business Overview

4.17 Novartis

4.17.1 Novartis Basic Information

4.17.2 Neurodegenerative Diseases Product Profiles, Application and Specification

4.17.3 Novartis Neurodegenerative Diseases Market Performance (2015-2020)

4.17.4 Novartis Business Overview

5 Global Neurodegenerative Diseases Market Analysis by Regions

5.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Regions

5.1.1 Global Neurodegenerative Diseases Sales by Regions (2015-2020)

5.1.2 Global Neurodegenerative Diseases Revenue by Regions (2015-2020)

5.2 North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.3 Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

5.6 South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

6 North America Neurodegenerative Diseases Market Analysis by Countries

6.1 North America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

6.1.1 North America Neurodegenerative Diseases Sales by Countries (2015-2020)

6.1.2 North America Neurodegenerative Diseases Revenue by Countries (2015-2020)

6.1.3 North America Neurodegenerative Diseases Market Under COVID-19

6.2 United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

6.2.1 United States Neurodegenerative Diseases Market Under COVID-19

6.3 Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

6.4 Mexico Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7 Europe Neurodegenerative Diseases Market Analysis by Countries

7.1 Europe Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

7.1.1 Europe Neurodegenerative Diseases Sales by Countries (2015-2020)

7.1.2 Europe Neurodegenerative Diseases Revenue by Countries (2015-2020)

7.1.3 Europe Neurodegenerative Diseases Market Under COVID-19

7.2 Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.2.1 Germany Neurodegenerative Diseases Market Under COVID-19

7.3 UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.3.1 UK Neurodegenerative Diseases Market Under COVID-19

7.4 France Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.4.1 France Neurodegenerative Diseases Market Under COVID-19

7.5 Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.5.1 Italy Neurodegenerative Diseases Market Under COVID-19

7.6 Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.6.1 Spain Neurodegenerative Diseases Market Under COVID-19

7.7 Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

7.7.1 Russia Neurodegenerative Diseases Market Under COVID-19

8 Asia-Pacific Neurodegenerative Diseases Market Analysis by Countries

8.1 Asia-Pacific Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Neurodegenerative Diseases Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Neurodegenerative Diseases Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Neurodegenerative Diseases Market Under COVID-19

8.2 China Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.2.1 China Neurodegenerative Diseases Market Under COVID-19

8.3 Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.3.1 Japan Neurodegenerative Diseases Market Under COVID-19

8.4 South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.4.1 South Korea Neurodegenerative Diseases Market Under COVID-19

8.5 Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.6 India Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.6.1 India Neurodegenerative Diseases Market Under COVID-19

8.7 Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Neurodegenerative Diseases Market Under COVID-19

9 Middle East and Africa Neurodegenerative Diseases Market Analysis by Countries

9.1 Middle East and Africa Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Neurodegenerative Diseases Market Under COVID-19

9.2 Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.3 UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.4 Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.5 Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

9.6 South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10 South America Neurodegenerative Diseases Market Analysis by Countries

10.1 South America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries

10.1.1 South America Neurodegenerative Diseases Sales by Countries (2015-2020)

10.1.2 South America Neurodegenerative Diseases Revenue by Countries (2015-2020)

10.1.3 South America Neurodegenerative Diseases Market Under COVID-19

10.2 Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10.2.1 Brazil Neurodegenerative Diseases Market Under COVID-19

10.3 Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10.4 Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

10.5 Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

11 Global Neurodegenerative Diseases Market Segment by Types

11.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Neurodegenerative Diseases Sales and Market Share by Types (2015-2020)

11.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Types (2015-2020)

11.2 NMDA Sales and Price (2015-2020)

11.3 SSRIs Sales and Price (2015-2020)

11.4 Dopamine Inhibitors Sales and Price (2015-2020)

12 Global Neurodegenerative Diseases Market Segment by Applications

12.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Neurodegenerative Diseases Sales and Market Share by Applications (2015-2020)

12.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Applications (2015-2020)

12.2 ParkinsonaEUR s Disease Sales, Revenue and Growth Rate (2015-2020)

12.3 Huntington Disease Sales, Revenue and Growth Rate (2015-2020)

12.4 Amyotrophic Lateral Sclerosis Sales, Revenue and Growth Rate (2015-2020)

12.5 AlzheimeraEUR s Disease Sales, Revenue and Growth Rate (2015-2020)

13 Neurodegenerative Diseases Market Forecast by Regions (2020-2026)

13.1 Global Neurodegenerative Diseases Sales, Revenue and Growth Rate (2020-2026)

13.2 Neurodegenerative Diseases Market Forecast by Regions (2020-2026)

13.2.1 North America Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.2 Europe Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.3 Asia-Pacific Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.4 Middle East and Africa Neurodegenerative Diseases Market Forecast (2020-2026)

13.2.5 South America Neurodegenerative Diseases Market Forecast (2020-2026)

13.3 Neurodegenerative Diseases Market Forecast by Types (2020-2026)

13.4 Neurodegenerative Diseases Market Forecast by Applications (2020-2026)

13.5 Neurodegenerative Diseases Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source


List Of Figure

List of Tables and Figures

Table Global Neurodegenerative Diseases Market Size Growth Rate by Type (2020-2026)

Figure Global Neurodegenerative Diseases Market Share by Type in 2019 & 2026

Figure NMDA Features

Figure SSRIs Features

Figure Dopamine Inhibitors Features

Table Global Neurodegenerative Diseases Market Size Growth by Application (2020-2026)

Figure Global Neurodegenerative Diseases Market Share by Application in 2019 & 2026

Figure ParkinsonaEUR s Disease Description

Figure Huntington Disease Description

Figure Amyotrophic Lateral Sclerosis Description

Figure AlzheimeraEUR s Disease Description

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Neurodegenerative Diseases Industry Development

Table SWOT Analysis

Figure Porter's Five Forces Analysis

Figure Global Neurodegenerative Diseases Market Size and Growth Rate 2015-2026

Table Industry News

Table Industry Policies

Figure Value Chain Status of Neurodegenerative Diseases

Figure Production Process of Neurodegenerative Diseases

Figure Manufacturing Cost Structure of Neurodegenerative Diseases

Figure Major Company Analysis (by Business Distribution Base, by Product Type)

Table Downstream Major Customer Analysis (by Region)

Table H.Lundbeck A/S Profile

Table H.Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020

Table Merck Profile

Table Merck Production, Value, Price, Gross Margin 2015-2020

Table Addex Pharmaceutical Profile

Table Addex Pharmaceutical Production, Value, Price, Gross Margin 2015-2020

Table Biogen Idec Profile

Table Biogen Idec Production, Value, Price, Gross Margin 2015-2020

Table Teva Profile

Table Teva Production, Value, Price, Gross Margin 2015-2020

Table Boehringer Ingelheim Profile

Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020

Table Yumanity Therapeutics Profile

Table Yumanity Therapeutics Production, Value, Price, Gross Margin 2015-2020

Table UCB Profile

Table UCB Production, Value, Price, Gross Margin 2015-2020

Table Alector Profile

Table Alector Production, Value, Price, Gross Margin 2015-2020

Table Eisai Profile

Table Eisai Production, Value, Price, Gross Margin 2015-2020

Table Asubio Pharmaceutical Profile

Table Asubio Pharmaceutical Production, Value, Price, Gross Margin 2015-2020

Table Bial Profile

Table Bial Production, Value, Price, Gross Margin 2015-2020

Table AstraZeneca Profile

Table AstraZeneca Production, Value, Price, Gross Margin 2015-2020

Table Pfizer Profile

Table Pfizer Production, Value, Price, Gross Margin 2015-2020

Table Amarin Profile

Table Amarin Production, Value, Price, Gross Margin 2015-2020

Table Bayer Profile

Table Bayer Production, Value, Price, Gross Margin 2015-2020

Table Novartis Profile

Table Novartis Production, Value, Price, Gross Margin 2015-2020

Figure Global Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Global Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table Global Neurodegenerative Diseases Sales by Regions (2015-2020)

Table Global Neurodegenerative Diseases Sales Market Share by Regions (2015-2020)

Table Global Neurodegenerative Diseases Revenue (USD ) by Regions (2015-2020)

Table Global Neurodegenerative Diseases Revenue Market Share by Regions (2015-2020)

Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2015

Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2019

Figure North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure North America Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table North America Neurodegenerative Diseases Sales by Countries (2015-2020)

Table North America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2015

Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2019

Table North America Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Mexico Neurodegenerative Diseases Sales and Growth (2015-2020)

Figure Europe Neurodegenerative Diseases Revenue (USD ) Growth (2015-2020)

Table Europe Neurodegenerative Diseases Sales by Countries (2015-2020)

Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Figure Europe Neurodegenerative Diseases Sales Market Share by Countries in 2015

Figure Europe Neurodegenerative Diseases Sales Market Share by Countries in 2019

Table Europe Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure France Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table Asia-Pacific Neurodegenerative Diseases Sales by Countries (2015-2020)

Table Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries in 2015

Figure Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries in 2019

Table Asia-Pacific Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure China Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure India Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure South America Neurodegenerative Diseases Revenue (USD ) and Growth (2015-2020)

Table South America Neurodegenerative Diseases Sales by Countries (2015-2020)

Table South America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020)

Table South America Neurodegenerative Diseases Revenue (USD ) by Countries (2015-2020)

Table South America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020)

Figure South America Neurodegenerative Diseases Revenue Market Share by Countries in 2015

Figure South America Neurodegenerative Diseases Revenue Market Share by Countries in 2019

Figure Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Figure Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020)

Table Global Neurodegenerative Diseases Sales by Types (2015-2020)

Table Global Neurodegenerative Diseases Sales Share by Types (2015-2020)

Table Global Neurodegenerative Diseases Revenue (USD ) by Types (2015-2020)

Table Global Neurodegenerative Diseases Revenue Share by Types (2015-2020)

Figure Global NMDA Sales and Growth Rate (2015-2020)

Figure Global NMDA Price (2015-2020)

Figure Global SSRIs Sales and Growth Rate (2015-2020)

Figure Global SSRIs Price (2015-2020)

Figure Global Dopamine Inhibitors Sales and Growth Rate (2015-2020)

Figure Global Dopamine Inhibitors Price (2015-2020)

Table Global Neurodegenerative Diseases Sales by Applications (2015-2020)

Table Global Neurodegenerative Diseases Sales Share by Applications (2015-2020)

Figure Global ParkinsonaEUR s Disease Sales and Growth Rate (2015-2020)

Figure Global ParkinsonaEUR s Disease Revenue and Growth Rate (2015-2020)

Figure Global Huntington Disease Sales and Growth Rate (2015-2020)

Figure Global Huntington Disease Revenue and Growth Rate (2015-2020)

Figure Global Amyotrophic Lateral Sclerosis Sales and Growth Rate (2015-2020)

Figure Global Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2015-2020)

Figure Global AlzheimeraEUR s Disease Sales and Growth Rate (2015-2020)

Figure Global AlzheimeraEUR s Disease Revenue and Growth Rate (2015-2020)

Figure Global Neurodegenerative Diseases Sales and Growth Rate (2020-2026)

Figure Global Neurodegenerative Diseases Revenue (USD ) and Growth Rate (2020-2026)

Table Global Neurodegenerative Diseases Sales Forecast by Regions (2020-2026)

Table Global Neurodegenerative Diseases Revenue Forecast by Regions (2020-2026)

Figure North America Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure North America Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure Europe Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure Europe Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure Asia-Pacific Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure Asia-Pacific Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure Middle East and Africa Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure Middle East and Africa Neurodegenerative Diseases Revenue Forecast (2020-2026)

Figure South America Neurodegenerative Diseases Sales Forecast (2020-2026)

Figure South America Neurodegenerative Diseases Revenue Forecast (2020-2026)

Table Global Neurodegenerative Diseases Sales Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Sales Market Share Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Revenue Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Types (2020-2026)

Table Global Neurodegenerative Diseases Sales Forecast by Applications (2020-2026)

Table Global Neurodegenerative Diseases Sales Market Share Forecast by Applications (2020-2026)

Table Global Neurodegenerative Diseases Revenue Forecast by Applications (2020-2026)

Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Applications (2020-2026)

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS